Qiming’s New Horizon Health gets listed on Hong Kong Stock Exchange
Category: #healthcare  By Mateen Dalal  Date: 2021-02-19
  • share
  • Twitter
  • Facebook
  • LinkedIn

Qiming’s New Horizon Health gets listed on Hong Kong Stock Exchange

Reportedly, Qiming-owned portfolio company, New Horizon Health recently, debuted as the first Chinese cancer early screening company to be listed on the Main Board of Hong Kong Stock Exchange.

Credible sources cited that this is the second IPO in Qiming’s portfolio this year, and the 14th public listing in the last 13 months.

Managing Partner of Qiming Venture Partners, Nisa Leung, on the matter stated that New Horizon will cover the big unmet cancer screening needs in China and early detection will hopefully improve the survival chances of cancer patients.

With New Horizon being an early market entrant, it has overcome regulatory and operational hurdles with strong clinical and R&D capacities, she added. 

She further expressed that Qiming is optimistic about the market and expects to see the company contributing to lowering cancer cases, improving patient survival rates, and benefiting global users.

For those unfamiliar, New Horizon Health, founded in 2015, is a cancer screening leader focused on the design, development, as well as commercialization of cancer screening tests. The company’s primary goal is to prevent and cure cancer through early detection and boasts of a portfolio of 71 patents and patent applications worldwide.

Trusted sources cited that New Horizon Health’s multi-parameter risk assessment algorithm is only of its kind for cancer screening. Its proprietary test, ColoClear, is the first and only molecular cancer screening testing in China approved by regulatory authorities, targeting 120 million high-risk colorectal cancer cases in the Chinese population.

Another proprietary test, Pupu Tube, targets a market of approximately 633 million population recommended for colorectal cancer screening. Moreover, the company has two late-stage product candidates for cervical and gastric cancer screening, confirmed sources.

With New Horizon Health now becoming a publicly-traded and owned entity, the company will have better opportunities to raise capital and invest its resources in catering to the needs of cancer patients.

Source Credits –

https://www.prnewswire.com/news-releases/first-cancer-early-screening-company-listed-on-hkex-as-new-horizon-health-debuts-301230549.html

About Author

Mateen Dalal    

Mateen Dalal

Despite working as a professional testing engineer, Mateen Dalal always held a liking for content creation. Following his passion, he now pens down articles for itresearchbrief.com and a couple of similar portals. Mateen is a qualified electronics and telecommunicat...

Read More>>

More News By Mateen Dalal

AstraZeneca sells its stake holding in Moderna for over US$1 billion
AstraZeneca sells its stake holding in Moderna for over US$1 billion
By Mateen Dalal

Moderna has projected an expected sales of $18.4 billion from its coronavirus vaccine in 2021 The...

Microsoft admits to short falling of vaccine tools following DC snags
Microsoft admits to short falling of vaccine tools following DC snags
By Mateen Dalal

American multinational technology conglomerate Microsoft Corporation has acknowledged the short fall...

Geely and Volvo Cars to launch powertrain entity, abandon merger talks
Geely and Volvo Cars to launch powertrain entity, abandon merger talks
By Mateen Dalal

Chinese multinational automotive giant Zhejiang Geely Holding Group Co. Ltd., commonly known as Geel...